Impact of Age-Adjusted Charlson Comorbidity score on outcomes for patients with early-stage endometrial cancer

Gynecologic Oncology

Volumn 131, Issue 3, 2013, Pages 593-597

  Robbins, Jared R ^a,b   Gayar, Omar H ^a   Zaki, Mark ^a   Mahan, Meredith ^a   Buekers, Thomas ^a   Elshaikh, Mohamed A ^a  

^a HENRY FORD HOSPITAL   (United States)

^b MEDICAL COLLEGE OF WISCONSIN   (United States)

Author keywords

Age adjusted Charlson; Comorbidity; Endometrial; Uterine

Indexed keywords

ADULT; AGE ADJUSTED CHARLSON COMORBIDITY INDEX; ARTICLE; CANCER GRADING; CANCER MORTALITY; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; CHARLSON COMORBIDITY INDEX; COMORBIDITY; DISEASE SPECIFIC SURVIVAL; ENDOMETRIUM CARCINOMA; FEMALE; FOLLOW UP; HISTOLOGY; HUMAN; HYSTERECTOMY; INSTITUTIONAL REVIEW; LYMPH VESSEL METASTASIS; MAJOR CLINICAL STUDY; MEDICAL RECORD REVIEW; OVERALL SURVIVAL; PHYSICIAN; PRIORITY JOURNAL; RECURRENCE FREE SURVIVAL; UTERUS;

AGE-ADJUSTED CHARLSON; COMORBIDITY; ENDOMETRIAL; UTERINE;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; CARCINOMA, ENDOMETRIOID; COMORBIDITY; ENDOMETRIAL NEOPLASMS; FEMALE; HUMANS; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; SEVERITY OF ILLNESS INDEX; UNITED STATES;

EID: 84888300053     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2013.10.007     Document Type: Article

References (21)

1. R. Siegel, D. Naishadham, and A. Jemal Cancer statistics, 2013 CA Cancer J Clin 63 2013 11 30
2. Z. Nicholas, N. Hu, J. Ying, P. Soisson, M. Dodson, and D.K. Gaffney Impact of Comorbid Conditions on Survival in Endometrial Cancer Am J Clin Oncol 2012 [published Online First: Epub Date 2012 Dec 13].
3. S.H. Olson, C.L. Atoria, M.L. Cote, L.S. Cook, R. Rastogi, and R.A. Soslow The impact of race and comorbidity on survival in endometrial cancer Cancer Epidemiol Biomarkers Prev 21 2012 753 760
4. K.K. Ward, N.R. Shah, C.C. Saenz, M.T. McHale, E.A. Alvarez, and S.C. Plaxe Cardiovascular disease is the leading cause of death among endometrial cancer patients Gynecol Oncol 126 2012 176 179
5. L.S. Cook, H.E. Nelson, M. Cockburn, S.H. Olson, C.Y. Muller, and C.L. Wiggins Comorbidities and endometrial cancer survival in Hispanics and non-Hispanic whites Cancer Causes Control 24 2013 61 69
6. A.R. Folsom, K.E. Anderson, C. Sweeney, and D.R. Jacobs Jr. Diabetes as a risk factor for death following endometrial cancer Gynecol Oncol 94 2004 740 745
7. P.T. Truong, H.A. Kader, B. Lacy, M. Lesperance, M.V. MacNeil, and E. Berthelet The effects of age and comorbidity on treatment and outcomes in women with endometrial cancer Am J Clin Oncol 28 2005 157 164
8. C.L. Creutzberg, W.L. van Putten, P.C. Koper, M.L.M. Lybeert, J.J. Jobsen, and C.C. Warlam-Rodenhuis Surgery and postoperative radiotherapy versus surgery alone for patients with stage-1 endometrial carcinoma: multicentre randomised trial. PORTEC Study Group. Post Operative Radiation Therapy in Endometrial Carcinoma Lancet 355 2000 1404 1411
9. H.M. Keys, J.A. Roberts, V.L. Brunetto, R.J. Zaino, N.M. Spirtos, and J.D. Bloss A phase III trial of surgery with or without adjunctive external pelvic radiation therapy in intermediate risk endometrial adenocarcinoma: a Gynecologic Oncology Group study Gynecol Oncol 92 2004 744 751
10. R.A. Nout, V.T. Smit, H. Putter, I.M. Jürgenliemk-Schulz, J.J. Jobsen, and L.C. Lutgens Vaginal brachytherapy versus pelvic external beam radiotherapy for patients with endometrial cancer of high-intermediate risk (PORTEC-2): an open-label, non-inferiority, randomised trial Lancet 375 9717 2010 816 823
11. B. Sorbe, G. Horvath, H. Andersson, K. Boman, C. Lundgren, and B. Pettersson External pelvic and vaginal irradiation versus vaginal irradiation alone as postoperative therapy in medium-risk endometrial carcinoma-a prospective randomized study Int J Radiat Oncol Biol Phys 82 2012 1249 1255
12. M.E. Charlson, P. Pompei, K.L. Ales, and C.R. MacKenzie A new method of classifying prognostic comorbidity in longitudinal studies: development and validation J Chronic Dis 40 1987 373 383
13. T.M. Koppie, A.M. Serio, A.J. Vickers, K. Vora, G. Dalbagni, and S.M. Donat Age-adjusted Charlson comorbidity score is associated with treatment decisions and clinical outcomes for patients undergoing radical cystectomy for bladder cancer Cancer 112 2008 2384 2392
14. J.R. Ouellette, D.G. Small, and P.M. Termuhlen Evaluation of Charlson-Age Comorbidity Index as predictor of morbidity and mortality in patients with colorectal carcinoma J Gastrointest Surg 8 2004 1061 1067
15. N. Kopek, M. Paludan, J. Petersen, A.T. Hansen, C. Grau, and M. Høyer Co-morbidity index predicts for mortality after stereotactic body radiotherapy for medically inoperable early-stage non-small cell lung cancer Radiother Oncol 93 2009 402 407
16. J. Marchena-Gomez, M.A. Acosta-Merida, M. Hemmersbach-Miller, A. Conde-Martel, C. Roque-Castellano, and J. Hernandez-Romero The age-adjusted Charlson Comorbidity Index as an outcome predictor of patients with acute mesenteric ischemia Ann Vasc Surg 23 2009 458 464
17. M. Charlson, T.P. Szatrowski, J. Peterson, and J. Gold Validation of a combined comorbidity index J Clin Epidemiol 47 1994 1245 1251
18. L.M. Byrd, R. Swindell, D. Webber-Rookes, R. Hannon, R.D. Hunter, J. Livsey, and S.E. Davidson Endometrial adenocarcinoma: an analysis of treatment and outcome Oncol Rep 20 2008 1221 1228
19. D. Boll, R.H. Verhoeven, M.A. van der Aa, M.L. Lybeert, J.W. Coebergh, and M.L. Janssen-Heijnen Adherence to national guidelines for treatment and outcome of endometrial cancer stage I in relation to co-morbidity in southern Netherlands 1995-2008 Eur J Cancer 47 2011 1504 1510
20. E. Steiner, O. Eicher, J. Sagemuller, M. Schmidt, H. Pilch, and B. Tanner Multivariate independent prognostic factors in endometrial carcinoma: a clinicopathologic study in 181 patients: 10 years experience at the Department of Obstetrics and Gynecology of the Mainz University Int J Gynecol Cancer 13 2003 197 203
21. A. Kauppila, M. Gronroos, and U. Nieminen Clinical outcome in endometrial cancer Obstet Gynecol 60 1982 473 480